Variant report
Variant | esv1813506 |
---|---|
Chromosome Location | chr6:78880271-78903094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:78884216..78887143-chr6:79140755..79143140,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540725087 | chr6:78891036-78891037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570914761 | chr6:78891219-78891220 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1338327 | chr6:78891238-78891239 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs577082815 | chr6:78891268-78891269 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532928330 | chr6:78891286-78891287 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549744554 | chr6:78891326-78891327 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186634496 | chr6:78891330-78891331 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192353257 | chr6:78891343-78891344 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75379942 | chr6:78891390-78891391 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183672433 | chr6:78891431-78891432 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142265175 | chr6:78891456-78891457 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557931062 | chr6:78891478-78891479 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573676384 | chr6:78891534-78891535 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34819371 | chr6:78891559-78891560 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571703899 | chr6:78891567-78891568 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537178307 | chr6:78891571-78891572 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144566518 | chr6:78891599-78891600 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111669843 | chr6:78891697-78891698 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574099901 | chr6:78891787-78891788 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543316577 | chr6:78891790-78891791 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553707428 | chr6:78891798-78891799 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372695013 | chr6:78891843-78891844 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545577180 | chr6:78891874-78891875 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568640995 | chr6:78891882-78891883 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540837726 | chr6:78891899-78891900 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201256299 | chr6:78891931-78891932 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185321540 | chr6:78891932-78891933 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs562907079 | chr6:78892000-78892001 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549141489 | chr6:78899006-78899007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117783400 | chr6:78899045-78899046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535085699 | chr6:78899058-78899059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181806176 | chr6:78899077-78899078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112203781 | chr6:78899082-78899083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551156063 | chr6:78899094-78899095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138330694 | chr6:78899119-78899120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375270165 | chr6:78899132-78899133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9443536 | chr6:78899142-78899143 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs185331301 | chr6:78899217-78899218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574364618 | chr6:78899227-78899228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114096707 | chr6:78899228-78899229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553496536 | chr6:78899248-78899249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573377563 | chr6:78899270-78899271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541072253 | chr6:78899282-78899283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9448322 | chr6:78899293-78899294 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs113860017 | chr6:78899303-78899304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543013674 | chr6:78899325-78899326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12204806 | chr6:78899326-78899327 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs529137739 | chr6:78899379-78899380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181581901 | chr6:78899440-78899441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9443537 | chr6:78899456-78899457 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:78891000-78891200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:78891000-78892000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr6:78891200-78891600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:78891600-78892000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:78892000-78892200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:78899000-78899400 | Enhancers | Fetal Intestine Large | intestine |
7 | chr6:78899400-78899600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr6:78901600-78902000 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
9 | chr6:78901600-78902200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:78901800-78902000 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:78901800-78902000 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:78901800-78902600 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
13 | chr6:78902000-78902400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |